A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
Abroad (travel likely)Recruiting
Conditions
Arthritis · Polymyalgia Rheumatica · Immune Checkpoint Inhibitors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Y. Jeff Li, MD)
Study leads
Y. Jeff Li, MD
Principal Investigator
M.D. Anderson Cancer Center